254 related articles for article (PubMed ID: 21491358)
21. Use of speech recognition software: a vocal endurance test for the new millennium?
Haxer MJ; Guinn LW; Hogikyan ND
J Voice; 2001 Jun; 15(2):231-6. PubMed ID: 11411476
[TBL] [Abstract][Full Text] [Related]
22. [Voice disorders caused by neurological diseases].
Gamboa J; Jiménez-Jiménez FJ; Mate MA; Cobeta I
Rev Neurol; 2001 Jul 16-31; 33(2):153-68. PubMed ID: 11562877
[TBL] [Abstract][Full Text] [Related]
23. Validation of a telephone screening tool for spasmodic dysphonia and vocal fold tremor.
Johnson DM; Hapner ER; Klein AM; Pethan M; Johns MM
J Voice; 2014 Nov; 28(6):711-5. PubMed ID: 24962230
[TBL] [Abstract][Full Text] [Related]
24. [Voice change and acoustic character of essential voice tremor].
Wang L; Dong J; Chen X; Wang T
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Sep; 20(18):817-9. PubMed ID: 17144486
[TBL] [Abstract][Full Text] [Related]
25. Development of a minimum protocol for assessment in the paediatric voice clinic. Part 1: evaluating vocal function.
Cohen W; Wynne DM; Kubba H; McCartney E
Logoped Phoniatr Vocol; 2012 Apr; 37(1):33-8. PubMed ID: 22149459
[TBL] [Abstract][Full Text] [Related]
26. Deviant vocal fold vibration as observed during videokymography: the effect on voice quality.
Verdonck-de Leeuw IM; Festen JM; Mahieu HF
J Voice; 2001 Sep; 15(3):313-22. PubMed ID: 11575628
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a crossover design study of unilateral versus bilateral injection.
Warrick P; Dromey C; Irish JC; Durkin L; Pakiam A; Lang A
Laryngoscope; 2000 Aug; 110(8):1366-74. PubMed ID: 10942143
[TBL] [Abstract][Full Text] [Related]
28. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
[TBL] [Abstract][Full Text] [Related]
29. Spastic/spasmodic vs. tremulous vocal quality: motor speech profile analysis.
Lundy DS; Roy S; Xue JW; Casiano RR; Jassir D
J Voice; 2004 Mar; 18(1):146-52. PubMed ID: 15070235
[TBL] [Abstract][Full Text] [Related]
30. Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia.
Wong DL; Adams SG; Irish JC; Durkin LC; Hunt EJ; Charlton MP
J Otolaryngol; 1995 Aug; 24(4):209-16. PubMed ID: 8551532
[TBL] [Abstract][Full Text] [Related]
31. Glottographic measures before and after levodopa treatment in Parkinson's disease.
Jiang J; Lin E; Wang J; Hanson DG
Laryngoscope; 1999 Aug; 109(8):1287-94. PubMed ID: 10443835
[TBL] [Abstract][Full Text] [Related]
32. Ventricular dysphonia: clinical aspects and therapeutic options.
Maryn Y; De Bodt MS; Van Cauwenberge P
Laryngoscope; 2003 May; 113(5):859-66. PubMed ID: 12792323
[TBL] [Abstract][Full Text] [Related]
33. A novel treatment for hypophonic voice: Twang therapy.
Lombard LE; Steinhauer KM
J Voice; 2007 May; 21(3):294-9. PubMed ID: 16527452
[TBL] [Abstract][Full Text] [Related]
34. Short-term effects of repetitive transcranial magnetic stimulation on speech and voice in individuals with Parkinson's disease.
Hartelius L; Svantesson P; Hedlund A; Holmberg B; Revesz D; Thorlin T
Folia Phoniatr Logop; 2010; 62(3):104-9. PubMed ID: 20424465
[TBL] [Abstract][Full Text] [Related]
35. Bilateral high-frequency electrical impulses to the thalamus reduce voice tremor: acoustic and electroglottographic analysis. A case report.
Moringlane JR; Pützer M; Barry WJ
Eur Arch Otorhinolaryngol; 2004 Jul; 261(6):334-6. PubMed ID: 14576948
[TBL] [Abstract][Full Text] [Related]
36. The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders.
Fox CM; Ramig LO; Ciucci MR; Sapir S; McFarland DH; Farley BG
Semin Speech Lang; 2006 Nov; 27(4):283-99. PubMed ID: 17117354
[TBL] [Abstract][Full Text] [Related]
37. The Distribution and Severity of Tremor in Speech Structures of Persons with Vocal Tremor.
Hemmerich AL; Finnegan EM; Hoffman HT
J Voice; 2017 May; 31(3):366-377. PubMed ID: 27289298
[TBL] [Abstract][Full Text] [Related]
38. Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment.
Ramig LO; Fox C; Sapir S
Semin Speech Lang; 2004 May; 25(2):169-80. PubMed ID: 15118943
[TBL] [Abstract][Full Text] [Related]
39. Clinical implementation of a multidimensional basic protocol for assessing functional results of voice therapy. A preliminary study.
Dejonckere PH
Rev Laryngol Otol Rhinol (Bord); 2000; 121(5):311-3. PubMed ID: 11387655
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and management of ventricular dysphonia.
Von Hake CP; Ganzman IP; Mauer TP
J Am Osteopath Assoc; 1989 Feb; 89(2):181-3. PubMed ID: 2925458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
